A

ApoGlyx

4 employees

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.

Basic info

Industry

biotechnology research

Sectors

Type 2 diabetes
Biotechnology
Sepsis
Drug Discovery
Aquaporin

Date founded

2015

Funding rounds raised

Total raised

$696K

from 1 investors over 1 rounds

A

ApoGlyx raised $696K on October 25, 2021

Investors: Almi Invest

FAQ